CYP2D6 and in vitro metabolism
731
Acknow ledgem ents
The authors are grateful to the Alberta Mental Health Research Fund and the
Medical Research Council for funding.
References
lva n
rind
raffner
joqvist
, F., 1984, Relationship of N-demethylation of
A
, G., G
ami¯amine and its metabolite to debrisoquine hydroxylation polymorphism. Clinical Phar-
36
, M., G
, C. and S
macology and Therapeutics, , 515±519.
eckett idha
, K. K., 1974, The identi®cation of four metabolic products after incubation
B
C
C
, A. H. and M
of p-methoxyamphetamine with liver preparations of various species. Xenobiotica , , 297±311.
, J., 1976, The metabolism of amphetamines in mammals. Drug Metabolism Reviews,
219±280.
iramatsu
4
5
aldwell
,
ho
hu
istefano
hang
enden
, A. S. and J , D. J., 1990, Stereochemical
, A. K., H
, M., D
, E. W., C
diåerences in the metabolism of 3,4-methylenedioxymethamphetamine in vivo and in vitro : a
18
pharmacokinetic analysis. Drug Metabolism and Disposition, , 686±691.
umagai tefano ho
, A. K., 1996, Disposition of methylene-
i
C
C
,
T.,
K
,
Y., D S
,
E. W. and
C
dioxymethamphetamine and three metabolites in the brains of diåerent rat strains and their
possible roles in acute serotonin depletion. Biochemical Pharmacology, 51, 789±796.
oleman
llis
artin
ennard
ucker
, M. S. and T , G. T., 1996, 1-Methyl-4-
phenyl-1,2,3,6-tetrahydropyridine (MPTP) is N-demethylated by cytochromes P450 2D6, 1A2
, T., E
, S. W., M
, I. J., L
and 3A4 ± implications for susceptibility to Parkinson’s disease. Journal of Pharmacology and
277
Experimental Therapeutics,
outts ach
685±690.
aker
C
C
C
, R. T., B
expressed in a human cell line. Xenobiotica , , 33±47.
outts olaji aker
, M. V. and B
, G. B., 1997, Metabolism of amitriptyline with CYP2D6
27
, G. B., 1994, Metabolism of methoxyphenamine in vitro
22
u
, O. O., S , P. and B
, R. T., B
by a CYP2D6 microsomal preparation. Drug Metabolism and Disposition, , 756±760.
outts awson
, G. W., 1977, Urinary excretion of phenolic metabolites of N-(n-
,
R. T. and
propyl)amphetamine in man. Research Communications in Chemical Pathology and Pharmacology,
17
D
, 349±352.
awson
outts
ones
, G. R., 1978, In vivo metabolism of N-alkylamphetamines in
C
C
C
D
D
G
, R. T., D
the rat ± the eåect of N-alkyl chain length on oxidation of the aromatic ring. Research
22
, G. W. and J
Communications in Chemical Pathology and Pharmacology, , 589±592.
outts awson azakoff ong
, J. Y., 1976, In vivo phenolic metabolites
, R. T., D
, G. W., K
, C. W. and W
of N-alkylamphetamines in the rat. Evidence in favor of catechol formation. Drug Metabolism and
4
Disposition , , 256±261.
outts ones
, R. T. and J
2-(n-propyl-amino) propane, an intermediate in N-(n-propyl)amphetamine metabolism. Research
36
, G. R., 1982, In vivo and in vitro O-methylation of 1-(3,4-dihydroxyphenyl)-
Communications in Chemical Pathology and Pharmacology, , 173±176.
ybring lwin lm ndreasson yllenpalm
ahl
ertilsson
,
, M. L., T
, G., E
, C. E., A , C., A
L., 1994, Stereoselective disposition of mianserin is related to debrisoquin hydroxylation
56
, K., G
, M. and B
polymorphism. Clinical Pharmacology and Therapeutics, , 176±183.
uncan allstrom aulsen orman indeke ho
carbon substituents on the N-demethylation of N-methyl-2-phenethylamines by rat liver
a
-S , B. and C , A. K., 1983, Eåects of -
, J. D., H
, G., P
, U., L
11
microsomes. Drug Metabolism and Disposition, , 15±20.
eertsen oster ilson yr
asley
, W., 1995, Metabolism of
, S., F
, B. C., W
, D. L., C , T. D. and C
methoxyphetamine and 2-methoxyamphetamine in P4502D6-transfected cells and cell
25
preparations. Xenobiotica , , 895±906.
orrod
G
G
, J. W., 1973, The metabolism and excretion of ` amphetamines’ in man. In Frontiers in
Catecholamine Research edited by E. Usdin and S. H. Snyder (Oxford : Pergamon), pp. 945±950.
race
inter
acdonald
, T. L., 1994, Atypical metabolism of deprenyl and its
, J. M., K
, M. T. and M
a
enantiomer (S)-( 1)-N, -dimethyl-N-propynylphenethylamine, by cytochrome P450 2D6.
7
Chemical Research in Toxicology, , 286±290.
iratsuka hu istefano in
, A., C , T. Y., D , E. W., L , L. Y., S
chmitz
ho
, D. A. and C , A. K., 1995,
H
K
K
K
Inactivation of constitutive hepatic cytochromes P450 by phencyclidine in the rat. Drug
23
Metabolism and Disposition, , 201±206.
itchen remblay ndre ring
1979, Interindividual and interspecies variation in the metabolism of the hallucinogen 4-
dle
mith
illiams
, R. T.,
, I., T
, J., A
, J., D
, L. G., I
, J. R., S
, R. L. and W
9
methoxyamphetamine. Xenobiotica , , 397±404.
obayashi urray atson esardic
avies
oobis
, A. R., 1989, The
, S., M
speci®city of inhibition of debrisoquine 4-hydroxylase activity by quinidine and quinine in the rat
38
, S., W
, D., S
, D., D
, D. S. and B
is the inverse of that in man. Biochemical Pharmacology, , 2795±2799.
umagai in iratsuka arimatsu uzuki amada
guri
, K.,
, Y., L , L. Y., H
, A., N
, S., S
, T., Y
, H., O